Managing glaucoma in 2026 has shifted from a “drops-first” approach to a more proactive, interventional strategy. For many Australians newly diagnosed with open-angle glaucoma or ocular hypertension, the primary choice now lies between Selective Laser Trabeculoplasty (SLT) and Minimally Invasive Glaucoma Surgery (MIGS). If you are weighing SLT Laser vs. MIGS to determine which initial glaucoma treatment is best for you, this guide provides a comprehensive, evidence-based comparison tailored to the Australian clinical landscape. We explore the mechanisms, benefits, and long-term outcomes of both pathways to help you make an informed decision with your ophthalmologist. See moer: Laser Eye Surgery After 40: Presbyopia Solutions and Blended Vision Options Understanding the…